S&P 500   4,600.95 (+1.38%)
DOW   35,283.63 (+2.03%)
QQQ   384.95 (+0.48%)
AAPL   166.13 (+2.65%)
MSFT   323.60 (+0.18%)
FB   315.29 (+2.75%)
GOOGL   2,849.86 (+0.35%)
AMZN   3,451.51 (+1.82%)
TSLA   998.27 (-1.65%)
NVDA   293.21 (-4.47%)
BABA   120.84 (+7.93%)
NIO   32.20 (+0.16%)
CGC   9.97 (-0.20%)
AMD   136.15 (-5.46%)
GE   96.53 (+4.05%)
MU   82.33 (+0.87%)
T   23.48 (+0.09%)
F   19.27 (+0.68%)
DIS   150.15 (+2.69%)
PFE   52.27 (-3.69%)
AMC   28.60 (-1.41%)
ACB   5.88 (+1.03%)
BA   204.97 (+3.26%)
S&P 500   4,600.95 (+1.38%)
DOW   35,283.63 (+2.03%)
QQQ   384.95 (+0.48%)
AAPL   166.13 (+2.65%)
MSFT   323.60 (+0.18%)
FB   315.29 (+2.75%)
GOOGL   2,849.86 (+0.35%)
AMZN   3,451.51 (+1.82%)
TSLA   998.27 (-1.65%)
NVDA   293.21 (-4.47%)
BABA   120.84 (+7.93%)
NIO   32.20 (+0.16%)
CGC   9.97 (-0.20%)
AMD   136.15 (-5.46%)
GE   96.53 (+4.05%)
MU   82.33 (+0.87%)
T   23.48 (+0.09%)
F   19.27 (+0.68%)
DIS   150.15 (+2.69%)
PFE   52.27 (-3.69%)
AMC   28.60 (-1.41%)
ACB   5.88 (+1.03%)
BA   204.97 (+3.26%)
S&P 500   4,600.95 (+1.38%)
DOW   35,283.63 (+2.03%)
QQQ   384.95 (+0.48%)
AAPL   166.13 (+2.65%)
MSFT   323.60 (+0.18%)
FB   315.29 (+2.75%)
GOOGL   2,849.86 (+0.35%)
AMZN   3,451.51 (+1.82%)
TSLA   998.27 (-1.65%)
NVDA   293.21 (-4.47%)
BABA   120.84 (+7.93%)
NIO   32.20 (+0.16%)
CGC   9.97 (-0.20%)
AMD   136.15 (-5.46%)
GE   96.53 (+4.05%)
MU   82.33 (+0.87%)
T   23.48 (+0.09%)
F   19.27 (+0.68%)
DIS   150.15 (+2.69%)
PFE   52.27 (-3.69%)
AMC   28.60 (-1.41%)
ACB   5.88 (+1.03%)
BA   204.97 (+3.26%)
S&P 500   4,600.95 (+1.38%)
DOW   35,283.63 (+2.03%)
QQQ   384.95 (+0.48%)
AAPL   166.13 (+2.65%)
MSFT   323.60 (+0.18%)
FB   315.29 (+2.75%)
GOOGL   2,849.86 (+0.35%)
AMZN   3,451.51 (+1.82%)
TSLA   998.27 (-1.65%)
NVDA   293.21 (-4.47%)
BABA   120.84 (+7.93%)
NIO   32.20 (+0.16%)
CGC   9.97 (-0.20%)
AMD   136.15 (-5.46%)
GE   96.53 (+4.05%)
MU   82.33 (+0.87%)
T   23.48 (+0.09%)
F   19.27 (+0.68%)
DIS   150.15 (+2.69%)
PFE   52.27 (-3.69%)
AMC   28.60 (-1.41%)
ACB   5.88 (+1.03%)
BA   204.97 (+3.26%)
NASDAQ:PTPI

Petros Pharmaceuticals News Headlines

$2.25
-0.23 (-9.27%)
(As of 12/6/2021 12:46 PM ET)
Add
Compare
Today's Range
$2.09
$2.46
50-Day Range
$1.33
$4.00
52-Week Range
$1.19
$5.96
Volume
53,974 shs
Average Volume
20.68 million shs
Market Capitalization
$32.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.61

Media Mentions By Week



Petros Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PTPI
News Sentiment

0.41

0.35

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PTPI Articles
This Week

9

0

PTPI Articles
Average Week

Get Petros Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter.

Petros Pharmaceuticals (NASDAQ:PTPI) News Headlines Today

SourceHeadline
finance.yahoo.com logoPetros Pharmaceuticals to Present at the Benzinga Global Small Cap Conference
finance.yahoo.com - December 2 at 2:15 PM
finance.yahoo.com logoPetros Pharmaceuticals Announces Closing of $10 Million Offering
finance.yahoo.com - December 2 at 2:15 PM
MarketBeat logoInsider Buying: Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) Director Buys 500,000 Shares of Stock
americanbankingnews.com - November 30 at 5:16 PM
finance.yahoo.com logoPetros Pharmaceuticals Announces $10 Million Offering
finance.yahoo.com - November 30 at 11:20 AM
thestreet.com logoTo The Moon: 2 Momentum Stocks To Watch This Week
thestreet.com - November 29 at 5:43 PM
markets.businessinsider.com logoWhat's Going On With Petros Pharmaceuticals Stock Today?
markets.businessinsider.com - November 29 at 5:43 PM
investorplace.com logoPTPI Stock: The Short-Squeeze Buzz That Has Petros Pharmaceuticals Rocketing Today
investorplace.com - November 29 at 10:01 AM
MarketBeat logoPetros Pharmaceuticals, Inc. (NASDAQ:PTPI) Short Interest Update
americanbankingnews.com - November 28 at 9:22 AM
MarketBeat logoPetros Pharmaceuticals, Inc. (NASDAQ:PTPI) Short Interest Down 22.2% in October
americanbankingnews.com - November 20 at 12:50 PM
finance.yahoo.com logoPetros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - November 15 at 9:14 PM
finance.yahoo.com logoPetros Pharmaceuticals to Present at the Q4 Investor Summit Conference
finance.yahoo.com - November 11 at 3:07 PM
finance.yahoo.com logoPetros Pharmaceuticals Expands Program for Novel Investigational Non-Invasive Treatment Formulation for Peyronie's Disease
finance.yahoo.com - November 8 at 10:50 AM
finance.yahoo.com logoPetros Pharmaceuticals, Inc. Through Exclusive Marketing Agreement with Hims & Hers Health, Inc. Generates 476% Year-Over-Year Growth of STENDRA Tablet Sales
finance.yahoo.com - November 3 at 9:59 AM
benzinga.com logoNotable Petros Pharmaceuticals Insider Makes $2.8M Buy
benzinga.com - October 21 at 2:37 PM
finance.yahoo.com logoPetros Pharmaceuticals to Participate at Upcoming Benzinga Conference and Interview Show
finance.yahoo.com - October 21 at 9:37 AM
finance.yahoo.com logoPetros Pharmaceuticals Announces Closing of $5.7 Million Registered Direct Offering
finance.yahoo.com - October 19 at 9:43 AM
finance.yahoo.com logoPetros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
finance.yahoo.com - October 14 at 1:23 PM
finance.yahoo.com logoPetros Pharmaceuticals to Present at the Benzinga Healthcare Small Cap Conference
finance.yahoo.com - September 23 at 9:59 AM
finance.yahoo.com logoPetros Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 10 at 4:09 PM
finance.yahoo.com logoPetros Pharmaceuticals Announces Second Quarter Financial Results and Provides Corporate Update; Reports a 123% Increase in Year Over Year Quarterly STENDRA® (avanafil) Net Sales
finance.yahoo.com - August 17 at 4:02 PM
barrons.com logoPetros Pharmaceuticals Inc.
barrons.com - August 14 at 7:27 AM
finance.yahoo.com logoPetros Pharmaceuticals to Present at Two Upcoming August Conferences
finance.yahoo.com - August 12 at 4:27 PM
benzinga.com logoPetros Pharmaceuticals
benzinga.com - July 31 at 7:56 AM
finance.yahoo.com logoPetros Pharmaceuticals Seeks to Disrupt the Prescription Erectile Dysfunction (ED) Market
finance.yahoo.com - July 29 at 5:30 PM
nasdaq.com logoFDA Grants Meeting To Petros Pharma To Discuss Label Expansion Of ED Drug Stendra - Quick Facts
nasdaq.com - July 27 at 12:39 PM
finance.yahoo.com logoFDA Grants Meeting to Petros Pharmaceuticals to Discuss Label Expansion of Erectile Dysfunction Drug STENDRA®
finance.yahoo.com - July 27 at 12:39 PM
bloomberg.com logoPetros Pharmaceuticals Inc
bloomberg.com - July 25 at 7:50 PM
benzinga.com logoPetros Pharmaceuticals Completes Pilot Label...
benzinga.com - July 13 at 12:47 PM
finance.yahoo.com logoPetros Pharmaceuticals Completes Pilot Label Comprehension Study to Initiate Process for Stendra® Prescription Erectile Dysfunction Medication to Achieve Designation as an Over-the-Counter Treatment
finance.yahoo.com - July 13 at 12:47 PM
finance.yahoo.com logoPetros Pharmaceuticals to Present at the Access to Giving Virtual Investor Conference on July 14, 2021
finance.yahoo.com - July 12 at 8:37 AM
finance.yahoo.com logoPetros Pharmaceuticals to Present at the LD Micro Virtual Invitational Conference on June 10, 2021
finance.yahoo.com - June 2 at 1:01 PM
finance.yahoo.com logoPetros Pharmaceuticals to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021
finance.yahoo.com - May 14 at 12:29 PM
finance.yahoo.com logoPetros Pharmaceuticals to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 13, 2021
finance.yahoo.com - May 7 at 9:41 AM
finance.yahoo.com logoRecently Published Research on Stendra®(avanafil) for Endothelial Function in Men with Erectile Dysfunction to Initiate Petros Pharmaceuticals' Plans for Expanded Labeling
finance.yahoo.com - March 18 at 12:30 PM
finance.yahoo.com logoPetros Pharmaceuticals Welcomes Dr. Mohit Khera to Steering Committee to Expand into Non-Rx Status for Stendra® (avanafil)
finance.yahoo.com - February 18 at 1:20 PM
msn.com logo12 Health Care Stocks Moving In Friday's Pre-Market Session
msn.com - February 12 at 1:43 PM
finance.yahoo.com logoPetros Pharmaceuticals to Participate in NobleCon17
finance.yahoo.com - February 1 at 10:54 AM
Get Petros Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTPI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.